Santheras Shareholders Approve all Board Proposals at Todays Annual General Meeting
Pratteln, Switzerland, May 26, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces…
Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update
Ad hoc announcement pursuant to Art. 53 LR A conference call will…
Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE Rollout
Ad hoc announcement pursuant to Art. 53 LR Highlights: Santhera secures approximately…
